Brief: Sana Biotechnology Reports Q3 2021 Financial Results
08/11/2021 21:45
Nov 8 (Reuters) - Sana Biotechnology Inc SANA.O :
* SANA BIOTECHNOLOGY REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS
AND BUSINESS UPDATES
* SANA BIOTECHNOLOGY INC QTRLY NON GAAP LOSS PER SHARE
$0.37
Source text for Eikon: ID:nGNXXzBzl
Further company coverage: SANA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sana Biotechnology
See all newsSana Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Sana Biotechnology Q2 adjusted loss narrows, beats estimates
Brief: Sana Biotechnology Q2 Adjusted EPS USD -0.13 Vs. IBES Estimate USD -0.15
Sana Biotechnology posts Q1 adjusted loss narrower than expected, extends cash runway
Brief: Sana Biotechnology Q1 Adjusted EPS USD -0.14 Vs. IBES Estimate USD -0.17